Opportunities abound….
....in the results deluge By Michael Crockett
AIM Rules require that a company reports its Half Year results within three months of the end of the period in question. Since over half of AIM companies have their year ending on 31 December there is always a scramble to get interim results out by the end of September. Consequently the last two weeks of September sees an absolute flood of half year reports.
Many of the results issued this month have made interesting reading. In this article I have highlighted four companies whose results particularly caught my eye in the interim results deluge. All four are small companies, valued at under £50 million, and each, in its own way, has considerable potential.
Follow Investors Champion’s comments on small caps daily on the Investors Champion Blog Showing promise at half time 1. Instem Life Science Systems (AIM:INS) www.instem.com Instem is a provider of IT solutions to the global life sciences community. The Company is well positioned within its industry with 500+ clients, including 24 of the top 25 pharma companies in the world. Instem’s interim results, issued on 19 September, reported that revenue had grown by 21% to £9.1 million and that profit (after currency and other adjustments) was up from £0.7 million to £1.0 million. Instem’s story has been growing nicely this…